Market Cap

Orphazyme A/S Market Capitalization:

kr.44.7 Million

DKK as of Jan. 1, 2024

US$6.6 Million

business Orphazyme A/S Company Profile

Orphazyme A/S Main Stock Listing

OMXC: ORPHA

Market Capitalization History of Orphazyme A/S

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Orphazyme A/S market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr.44.7 M 37.57%
Jan. 1, 2023 kr.32.5 M -93.35%
Jan. 1, 2022 kr.488.5 M -81.65%
Jan. 1, 2021 kr.2.66 B -42.79%
Jan. 1, 2020 kr.4.65 B 143.86%
Jan. 1, 2019 kr.1.91 B -31.48%
Jan. 1, 2018 kr.2.79 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Orphazyme A/S Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Orphazyme A/S has the following listings and related stock indices.


Stock: OMXC: ORPHA

Stock: NASDAQ: ORPH

Stock: FSX: 1TB

Stock: FSX: 1TBD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.